Adult Vaccinations

Key Takeaways The HPV vaccine can reduce the risk of developing certain cancers in both men and women. Recent research found that males and females experience similar side effects—and benefits—of the HPV vaccine. The most common side effect is fainting after getting the shot, but it does not lead to any long-term issues. When a vaccine to protect against the most common forms of human papillomavirus (HPV) was first released, it was largely marketed for preteen girls. A growing body of evidence has shown that boys can benefit from the vaccine. Now, new research has found that the shot is also safe for boys. A new analysis published in the  British Journal of Clinical Pharmacology  found that HPV vaccines are safe and well-tolerated in males (previous research had largely focused on females). The analysis also found that the potential side effects are similar to what female patients have reported. The analysis studied 5,493 adverse events following immunization that...

Key Takeaways The HPV vaccine can reduce the risk of developing certain cancers in both men and women. Recent research found that males and females experience similar side effects—and benefits—of the HPV vaccine. The most common side effect is fainting after getting the shot, but it does not lead to any long-term issues. When a vaccine to protect against the most common forms of human papillomavirus (HPV) was first released, it was largely marketed for preteen girls. A growing body of evidence has shown that boys can benefit from the vaccine. Now, new research has found that the shot is also safe for boys. A new analysis published in the  British Journal of Clinical Pharmacology  found that HPV vaccines are safe and well-tolerated in males (previous research had largely focused on females). The analysis also found that the potential side effects are similar to what female patients have reported. The analysis studied 5,493 adverse events following immunization that...

Quadrivalent human papillomavirus (HPV) vaccination was associated with a substantially reduced risk of invasive cervical cancer, according to data published in The New England Journal of Medicine . This study followed an open population of 1,672,983 Swedish girls and women between 10 and 30 years of age until they reached 31 years of age. Of these, 527,871 received at least 1 dose of HPV vaccine during the study period from 2006 through 2017 with 438,939 (83.2%) receiving the vaccine before the age of 17. Cervical cancer was diagnosed in 19 women who had received the vaccine and 538 who did not receive the vaccine. The cumulative incidence in each of these groups was 47 and 94 cases per 100,000 persons, respectively, by 30 years of age. In both the vaccinated and unvaccinated groups, the cumulative incidence of cervical cancer increased rapidly at 23 years of age. For women who received the vaccine before 17 years of age, cumulative incidence was 4 cases per 100,000 persons by th...

BY LINDSEY BARK Reporter 10/25/2020 09:00 AM HPV is a sexually transmitted virus, spread through intimate skin-to-skin contact, known to cause genital warts and certain types of cancers. It’s recommended that children get two doses of the HPV vaccine starting at ages 11-12, though the earliest vaccination can be started at 9 years old, to help prevent cancer-causing infections. COURTESY TAHLEQUAH – In a 2018 U.S. Cancer Statistics data brief, the most recent data shows from 1999 to 2015 that there were approximately 2,725 human papillomavirus-associated cancer cases among the Native American population. HPV is a sexually transmitted virus, spread through intimate skin-to-skin contact, known to cause genital warts and certain cancers. “While most HPV infections will go away on their own, the infections that don’t go away can cause certain types of cancer,” states the Centers for Disease Control website. Cervical cancer is the most common HPV-associated cancer among Nativ...

Beginning Jan. 1, 2021, the Human Papillomavirus (HPV) vaccine will be available to all Yukoners up to, and including, age 26. The territory announced the change to the vaccine program Oct. 19, noting that the current program is only available to girls ages nine to 18 and boys ages nine to 14. “We are pleased to be expanding the HPV vaccination program to include all individuals up to their 27th birthday,” Health and Social Services Minister Pauline Frost said in a statement. “Expanding the eligibility for this immunization will offer more Yukoners protection from HPV-related cancers caused by HPV. Increased funding for public vaccine coverage was a recommendation in the Putting People First report and will improve Yukoners well-being and quality of life.” HPV is a common virus spread mainly through sexual contact. It’s estimated that three out of four sexually active people will get HPV at some point in their lives and that HPV infection is related to almost all cases of cervical...

KENDALLVILLE — Public attention seems to be focused on one vaccine in particular — one for COVID-19. However, a recent study is suggesting that there’s another vaccine, which is already available, that Hoosiers could be utilizing more. In a study by WalletHub titled 2020’s States that Vaccinate the Most, Indiana ranks 38 out of 51 states (including D.C.) for all vaccines, but second to last in the number of teens vaccinated for Human Papillomavirus, or HPV. Out of teenagers aged 13-17 with an up-to-date HPV vaccine, Indiana ranks only above Mississippi. Medical professionals are seeing this trend in northeast Indiana, as well. “The HPV vaccine is definitely something that is very misunderstood,” Noble County Department of Health Public Health Nurse Cheryl Munson said. Munson said many have inaccurate and scary information about the HPV vaccine. And because it’s not required for kids to attend K-12 school, parents are sometimes inclined to opt out of the vaccine for th...

Quadrivalent human papillomavirus (HPV) vaccination was associated with a substantial reduction in the incidence of cervical cancer in a Swedish review of more than 1 million girls and women vaccinated from 2006–2017. It's been shown that the vaccine (Gardasil) helps prevent genital warts and high-grade cervical lesions, but until now, data on the ability of the vaccine to prevent cervical cancer, although widely assumed, had been lacking. "Our results extend [the] knowledge base by showing that quadrivalent HPV vaccination is also associated with a substantially reduced risk of invasive cervical cancer, which is the ultimate intent of HPV vaccination program," said investigators led by Jiayao Lei, PhD, a researcher in the Department of Medical Epidemiology and Biostatistics at the Karolinska Institute, Stockholm, Sweden. The study was published online October 1 in The New England Journal of Medicine . "This work provides evidence of actual cancer prevention,...

The authors of a 2018 paper purporting to find that the HPV vaccine guards against preterm birth have retracted the article after discovering they made a statistical error which could have masked the opposite effect. The researchers, from New Zealand, also failed to appropriately disclose their financial ties to a company, CSL Limited, which owns the rights to the HPV vaccine in Australia and New Zealand. The paper, "Association of prior HPV vaccination with reduced preterm birth: A population based study," was published in Vaccine , an Elsevier journal. According to the abstract: Emerging evidence suggests that HPV infection is associated with negative pregnancy outcomes such as preterm birth (PTB), and pre-eclampsia. We aimed to determine if prior HPV vaccination reduced adverse pregnancy outcomes. … PTB (OR: 0.87; CI 0.78, 0.96)) was significantly lower for women who previously received the HPV vaccine. A dose response effect was found with each successive dose receiv...

× Thanks for reading! Log in to continue. Enjoy more articles by logging in or creating a free account. No credit card required. Why is it so important for kids to receive the HPV vaccination, even as we deal with a pandemic? Life can be unpredictable, and nothing has proved that more than 2020. The global pandemic has been dominating the news cycle, and everyone is now familiar with the devastation caused by viruses like COVID-19, especially the impact of asymptomatic carriers on spreading the disease. However, the fact that some cancers also can spread virally is much less well known. Cancer remains the second-leading cause of death in the developed world, and it is often perceived as inevitable. Cancers that are due to certain viral infections, however, can be prevented by vaccination, providing the vaccination happens before exposure to the cancer-causing virus. Every parent should be aware of human papilloma virus (HPV)-associated cancers — and that vaccinat...

Human papillomavirus (HPV) vaccination coverage has lagged in the United States. A report looks at whether the coverage will meet the Healthy People 2020 goal. Routine immunization has been a topic of much discussion over at least the past decade. Many of those vaccinations still occur in enough high enough numbers to do good. However, the human papillomavirus (HPV) vaccine has fought an uphill battle to be accepted in the United States. Other countries are well on their way to meeting their HPV vaccination goals, but the United States has frequently lagged behind. A new report in Pediatrics looks at whether the country will meet the Healthy People 2020 goal of 80% vaccine coverage. 1 Investigators used the MarketScan health care database to find participants. The children included in the study were followed from when they reached their 9th birthday until they received the HPV vaccination, were disenrolled from insurance, or had reached their 17th birthday, whichever came first. ...

Dear Editor, You may know the HPV (human papillomavirus) vaccine best for its prevention of cervical cancer.  Now the vaccine is approved for use against head, neck and throat cancer. More than 35,000 HPV-related cancers are found each year. About 13,500 are cancers of the throat. The Cancer Prevention in Action Program (CPiA) works to increase HPV vaccination rates in children in order to prevent cancer in adulthood. Head, neck and throat cancers are more common among men and among people over the age of 50. The HPV vaccine is given to boys and girls beginning at age nine and through age 26.  Unfortunately, close to half of adolescents in New York State do not get the vaccine when they should. Because of COVID-19, many parents have had to delay regular health care visits when vaccines are given. If you’ve had to put off your child’s vaccinations, now is the time to get them back on your calendar. You may wonder if it is safe to have a health care visit, but medical office...

Free human papillomavirus vaccinations will be provided to girls aged 13 to 14 and a half in Xiamen, Fujian province, until the end of 2022 to help prevent cervical cancer. The city's health commission announced the move this month, making it the second region in the country to adopt such a policy. The first was Juungar Banner in Ordos, in the Inner Mongolia autonomous region, which did so last month. Xiamen's Haicang district is expected to kick off the free HPV vaccination project by the end of this month, local news website Zaker reported on Saturday. Girls will be offered a domestically made two-valent HPV vaccine offering protection from two types of HPV, the Xiamen health commission said in a notice. All community health service centers in the city will be able to provide vaccinations based on lists of names provided by schools, where students and parents will be able to apply. The cost of the vaccines and the service fees will be paid by the local government. Girls a...

Dear Doctor: Everyone talks about girls getting the HPV vaccine. But what about boys? Isn’t it just as important for boys to be vaccinated as well? Dear Reader: You’re referring to the vaccination for human papillomavirus, or HPV. And you’re correct that the vaccination is important for both girls and boys. HPV is the most common sexually transmitted infection in the United States, and it can lead to several types of cancer later in life. About 80 million people in the U.S. are currently infected with some type of the virus. About 14 million more, mostly teens and young adults, become infected every year. HPV refers to a group of more than 200 related viruses. Of these, more than 40 are spread through direct sexual contact. The majority of HPV infections clear up on their own, often in about two years. The rest, however, can linger. They can lead to health problems that range from mild to life-threatening. Some cause genital warts and are considered to be low-risk. Others can caus...

Dear Doctor: Everyone talks about girls getting the HPV vaccine. But what about boys? Isn’t it just as important for boys to be vaccinated as well? Dear Reader: You’re referring to the vaccination for human papillomavirus, or HPV. And you’re correct that the vaccination is important for both girls and boys. HPV is the most common sexually transmitted infection in the United States, and it can lead to several types of cancer later in life. About 80 million people in the U.S. are currently infected with some type of the virus. About 14 million more, mostly teens and young adults, become infected every year. HPV refers to a group of more than 200 related viruses. Of these, more than 40 are spread through direct sexual contact. The majority of HPV infections clear up on their own, often in about two years. The rest, however, can linger. They can lead to health problems that range from mild to life-threatening. Some cause genital warts and are considered to be low-risk. Others ...

Dear Doctor: Everyone talks about girls getting the HPV vaccine. But what about boys? Isn't it just as important for boys to be vaccinated as well? Dear Reader: You're referring to the vaccination for human papillomavirus, or HPV. And you're correct that the vaccination is important for both girls and boys. HPV is the most common sexually transmitted infection in the United States, and it can lead to several types of cancer later in life. About 80 million people in the U.S. are currently infected with some type of the virus. About 14 million more, mostly teens and young adults, become infected every year. HPV refers to a group of more than 200 related viruses. Of these, more than 40 are spread through direct sexual contact. The majority of HPV infections clear up on their own, often in about two years. The rest, however, can linger. They can lead to health problems that range from mild to life-threatening. Some cause genital warts and are considered to be low-risk. O...

[embedded content] It can cause throat cancer and cervical cancer. “Once you’re infected with HPV, you will have it in your system for life,” explained Dr. Denise Drago, a pediatrician with Lee Health. Which is why doctors are educating families on the benefits of the HPV vaccine. “You want to protect your kids before they are really at risk. The vaccine won’t reverse the HPV you already have, but it can protect against the strains you don’t have that are in the vaccine,” she said. The HPV vaccine can be given to children as young as nine years old. Studies show the vaccine is most effective between the ages of 9 and 14. “If you get the vaccine under 15, you get one shot and then one shot six months later, so it’s two doses, and if you get it after 15, it’s three doses,” said Dr. Drago. HPV is transmitted sexually. Doctors say the goal, is to give children the vaccine before they become sexually active. “The vaccine actually works better the younger you are,” she said. The HPV ...

“Ensuring that individuals adhere to a five‐year screening interval poses challenges for patients, clinicians, and payers,” the guideline committee wrote in CA: A Cancer Journal for Clinicians . “For patients, keeping track of when they are due for screening may be, and likely will be, more difficult than keeping track of short‐interval testing. For clinicians, harnessing registries to monitor the screening status of all women is crucial but may be more difficult for longer interval testing.”

The American Cancer Society's new guidance on human papillomavirus vaccination diverges from the Centers for Disease Control and Prevention's recommendations. The ACS has endorsed two recommendations made by the CDC's Advisory Committee on Immunization Practices, but the ACS does not agree with a third recommendation for older adults. The ACIP recommends shared clinical decision-making regarding human papillomavirus (HPV) vaccination in some adults aged 27-45 years who are not adequately vaccinated. The ACS does not endorse this recommendation "because of the low effectiveness and low cancer prevention potential of vaccination in this age group, the burden of decision-making on patients and clinicians, and the lack of sufficient guidance on the selection of individuals who might benefit," wrote Debbie Saslow, PhD, of the ACS's section on human papillomavirus and gynecologic cancers, and colleagues. Dr. Saslow and colleagues detailed the ACS recommendations...

The human papillomavirus (HPV) vaccine is the key to a major public health victory, but the vaccine coverage has been less than effective. A report offers some answer to how parental intent has made an impact. The human papillomavirus (HPV) vaccine has been a public health victory and some countries are close to making cervical cancer a thing of the past because of it. However, in the United States, the uptake of the vaccine is largely dependent on parents. A report that aims to quantify parental intentions to start and complete the HPV vaccine in the United States was published in the Lancet Public Health . 1 Investigators did a cross-sectional study that used data from the adolescent component of the 2017-2018 National Immunization Survey. The study participants were parents or caregivers of US teenagers aged 13 to 17 years. The study’s primary outcome was the parent’s intent to vaccinate the teenager for HPV in the next year. The secondary outcomes were the prevalence of reason...

The human papillomavirus (HPV) vaccine has been proven to prevent certain types of oral and genital cancers and other health problems. However, in a study published this week in Lancet Public Health, researchers found that more than half of the parents of adolescents who have not received the HPV vaccine had no intention to initiate the vaccine series for their children. Using data from a nationally representative survey of U.S. adolescents, the study authors estimated national-level and state-level parental intent to initiate and complete the HPV vaccine series for their kids. In states including Idaho, Montana, Nebraska, North Dakota, Oklahoma and Utah, more than 65% of parents of unvaccinated adolescents had no intention to initiate the HPV vaccine series. According to the most recent data by the Centers for Disease Control and Prevention, Wyoming and Mississippi have the lowest HPV vaccine rates at roughly 50%. The new study found that of parents of unvaccinated adolescents in t...